Biotech China 2014
Anti-inflammatories: Small Molecule Approaches
Hilton San Diego Resort

San Diego, California
http://www.drugdiscoverychemistry.com/
   Speakers
   --------

   N/A

   The hunt for new small molecules that target inflammation is heating
   up. Researchers are discovering that inflammation plays a central role
   in a wide range of diseases, from rheumatoid arthritis to cancer and
   Alzheimer’s. Current oral therapies such as Cox-2 inhibitors and
   NSAIDs can have undesirable and significant side effects with frequent
   use. The promising biologics on the horizon have the downside that
   they are more costly than small molecule therapeutics and cannot be
   taken orally. CHI’s inaugural Anti-inflammatories meeting is one of
   the only conferences to focus on combating inflammation with small
   molecules.

Schedule of Presentations:

Tuesday, April 27, 2010
07:00:00 Registration and Morning Coffee
08:10:00 Discovery of CP-690,550: A Potent and Selective JAK Inhibitor for the Treatment of Autoimmune Diseases and Renal Allograft Rejection Mark Flanagan
08:50:00 Development of a JAK-inhibitor for Rheumatoid Arthritis Jonathan Fridman
09:20:00 Optimization of a Series of Tricyclic Inhibitors of 1 Kappa B Kinase Inhibitors and Efficacy in Chronic Murine Models of Arthritis William Pitts
09:50:00 Networking Coffee Break
10:15:00 A Novel Covalent Inhibitor of BTK Inhibits B Cell ReceptorSignaling and Demonstrates Efficacy in Rheumatoid Arthritis Models Juswinder Singh
10:45:00 Novel Small Molecule Inhibitors of BTK (Bruton’s Tyrosine Kinase) Wei Chen
11:15:00 Sponsored Presentation (Opportunity Available)
11:30:00 Presentation to be Announced
12:00:00 Luncheon Presentation (Sponsorship Opportunity Available) or Lunch on Your Own
13:20:00 New Inflammation Targets And Pathways
13:25:00 Chairperson's Remarks
13:30:00 A Target for Drug Discovery in Autoimmune and Inflammatory Diseases Yousef Al-Abed
14:00:00 Hydrogen Sulfide-Releasing Anti-Inflammatory Drugs John Wallace
14:30:00 Panel Session: Drug Development Challenges in Autoimmunity/Inflammation
15:00:00 Sponsored Presentation (Opportunity Available)
15:15:00 Networking Refreshment Break, Poster and Exhibit Viewing
15:55:00 New Inflammation Targets And Pathways (Continued)
16:00:00 Small Molecule CRAC Channel Inhibitors for the Treatment of Autoimmune and Inflammatory Diseases Jeffrey Whitten
16:30:00 Identification of the Bioactive Constituent and its Mechanisms of Action in Mediating the Anti-Inflammatory Effects of Black Cohosh and Related Cimicifuga Allan SY Lau
17:00:00 Tetrac Acts at a Plasma Membrane Receptor to Modulate Expression of Inflammation-Related Genes Paul Davis
17:30:00 Networking Cocktail Reception in the Exhibit Hall
18:30:00 End of Day
Wednesday, April 28, 2010
07:45:00 Continental Breakfast Break-Out Discussions
08:50:00 MODULATING THE IMMUNE SYSTEM
08:55:00 Chairperson's Opening Remarks
09:00:00 Synthesis and SAR of 2-Pyridinylbenzimidazoles as Human Histamine H4 Antagonists Jennifer Venable
09:30:00 CPSI-2364: An Orally Efficacious Inhibitor of Proinflammatory Cytokine Production for Autoimmune and Inflammatory Diseases Vidal de la Cruz
10:00:00 Sponsored Presentation (Opportunity Available)
10:15:00 Coffee Break, Poster and Exhibit Viewing
11:00:00 Presentation to be Announced
11:30:00 Narrow Spectrum Inhibitors of cFMS, cKIT, and PDGFR Kinases as Therapies for Rheumatoid Arthritis and other Autoimmune Diseases Daniel Flynn
12:00:00 End of Conference
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.